Search

everythinglearnresearchcommunity

for

Search:↓

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Adiantum capillus extract reduces pain and swelling in animals.

The AI showed high accuracy in diagnosing skin conditions but needs improvement for immunological and infectious disorders.

People with androgenetic alopecia have a higher risk of heart disease.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Eclipta alba extract is generally safe with mild liver and kidney changes at high doses.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Farudodstat may effectively treat alopecia areata without harmful side effects.

The DLQI is a key tool for measuring quality of life in dermatology.

Androgenetic alopecia affects men's emotions more than symptoms or daily function.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Baricitinib was effective in treating both early and late onset alopecia areata.

The document concludes that a new questionnaire to assess mental health in alopecia patients shows low rates of seeking mental health services and support groups.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.